Syndax Pharmaceuticals, Inc.

NasdaqGS:SNDX Stock Report

Market Cap: US$1.9b

Syndax Pharmaceuticals Balance Sheet Health

Financial Health criteria checks 5/6

Syndax Pharmaceuticals has a total shareholder equity of $554.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $612.9M and $58.7M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$577.58m
EquityUS$554.20m
Total liabilitiesUS$58.68m
Total assetsUS$612.88m

Recent financial health updates

Recent updates

Syndax Pharmaceuticals: Upcoming Q3 PDUFAs Ignite Hope

Mar 28

Here's Why We're Not Too Worried About Syndax Pharmaceuticals' (NASDAQ:SNDX) Cash Burn Situation

Mar 04
Here's Why We're Not Too Worried About Syndax Pharmaceuticals' (NASDAQ:SNDX) Cash Burn Situation

Is Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Trading At A 46% Discount?

Nov 20
Is Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Trading At A 46% Discount?

Companies Like Syndax Pharmaceuticals (NASDAQ:SNDX) Are In A Position To Invest In Growth

Sep 27
Companies Like Syndax Pharmaceuticals (NASDAQ:SNDX) Are In A Position To Invest In Growth

Syndax Pharmaceuticals Q2 2022 Earnings Preview

Aug 07

Syndax Pharmaceuticals: Cash-Rich With 2 Promising Drugs

Apr 08

Is Syndax Pharmaceuticals (NASDAQ:SNDX) Weighed On By Its Debt Load?

Jun 11
Is Syndax Pharmaceuticals (NASDAQ:SNDX) Weighed On By Its Debt Load?

Shareholders Would Not Be Objecting To Syndax Pharmaceuticals, Inc.'s (NASDAQ:SNDX) CEO Compensation And Here's Why

May 07
Shareholders Would Not Be Objecting To Syndax Pharmaceuticals, Inc.'s (NASDAQ:SNDX) CEO Compensation And Here's Why

The Syndax Pharmaceuticals (NASDAQ:SNDX) Share Price Has Gained 150%, So Why Not Pay It Some Attention?

Mar 15
The Syndax Pharmaceuticals (NASDAQ:SNDX) Share Price Has Gained 150%, So Why Not Pay It Some Attention?

Financial Position Analysis

Short Term Liabilities: SNDX's short term assets ($580.9M) exceed its short term liabilities ($58.1M).

Long Term Liabilities: SNDX's short term assets ($580.9M) exceed its long term liabilities ($588.0K).


Debt to Equity History and Analysis

Debt Level: SNDX is debt free.

Reducing Debt: SNDX had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: SNDX has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if SNDX has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.